Jean W. Assender

497 total citations
13 papers, 423 citations indexed

About

Jean W. Assender is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jean W. Assender has authored 13 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jean W. Assender's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Receptor Mechanisms and Signaling (3 papers). Jean W. Assender is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Receptor Mechanisms and Signaling (3 papers). Jean W. Assender collaborates with scholars based in United Kingdom, Sweden and Japan. Jean W. Assender's co-authors include Andrew C. Newby, Kay M. Southgate, Maurice B. Hallett, Eva Irenius, Ewa Kontny, Bertil B. Fredholm, Bertil B. Fredholm, Robert I. Nicholson, Mark Bond and Liang‐Fong Wong and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

Jean W. Assender

13 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean W. Assender United Kingdom 11 243 139 90 57 47 13 423
Talat Afroze Canada 12 261 1.1× 71 0.5× 102 1.1× 42 0.7× 28 0.6× 20 512
Ursula Baur Switzerland 11 263 1.1× 164 1.2× 123 1.4× 65 1.1× 23 0.5× 11 573
Jérôme Terrand France 14 316 1.3× 91 0.7× 141 1.6× 90 1.6× 53 1.1× 23 675
R. Kast Germany 8 216 0.9× 71 0.5× 80 0.9× 31 0.5× 33 0.7× 11 386
Edith Giasson Canada 9 396 1.6× 125 0.9× 169 1.9× 45 0.8× 67 1.4× 9 560
Josef Pfeilschifter Switzerland 11 301 1.2× 78 0.6× 39 0.4× 62 1.1× 50 1.1× 12 471
A. Sandra United States 14 341 1.4× 114 0.8× 72 0.8× 41 0.7× 33 0.7× 32 541
Ruqin Kou United States 10 345 1.4× 278 2.0× 133 1.5× 57 1.0× 34 0.7× 11 620
P.G. Suh South Korea 15 495 2.0× 101 0.7× 39 0.4× 45 0.8× 58 1.2× 28 732
Tasuku Yokota Japan 11 129 0.5× 110 0.8× 82 0.9× 37 0.6× 34 0.7× 13 446

Countries citing papers authored by Jean W. Assender

Since Specialization
Citations

This map shows the geographic impact of Jean W. Assender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean W. Assender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean W. Assender more than expected).

Fields of papers citing papers by Jean W. Assender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean W. Assender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean W. Assender. The network helps show where Jean W. Assender may publish in the future.

Co-authorship network of co-authors of Jean W. Assender

This figure shows the co-authorship network connecting the top 25 collaborators of Jean W. Assender. A scholar is included among the top collaborators of Jean W. Assender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean W. Assender. Jean W. Assender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Assender, Jean W., Julia M.W. Gee, Ian Lewis, et al.. (2007). Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer. Journal of Clinical Pathology. 60(11). 1216–1221. 49 indexed citations
2.
Fredholm, Bertil B., Jean W. Assender, Eva Irenius, Noriko Kodama, & Naoaki Saito. (2003). Synergistic Effects of Adenosine A1 and P2Y Receptor Stimulation on Calcium Mobilization and PKC Translocation in DDT1 MF-2 Cells. Cellular and Molecular Neurobiology. 23(3). 379–400. 18 indexed citations
3.
Hussain, Shaista, Jean W. Assender, Mark Bond, et al.. (2002). Activation of Protein Kinase Cζ Is Essential for Cytokine-induced Metalloproteinase-1, -3, and -9 Secretion from Rabbit Smooth Muscle Cells and Inhibits Proliferation. Journal of Biological Chemistry. 277(30). 27345–27352. 57 indexed citations
4.
Harper, M. E., Lindy Goddard, Jean W. Assender, et al.. (2002). Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor. The Prostate. 52(1). 59–68. 17 indexed citations
5.
6.
Assender, Jean W., Eva Irenius, & Bertil B. Fredholm. (1996). Endothelin‐1 causes a prolonged protein kinase C activation and acts as a co‐mitogen in vascular smooth muscle cells. Acta Physiologica Scandinavica. 157(4). 451–460. 39 indexed citations
7.
Assender, Jean W., Eva Irenius, & Bertil B. Fredholm. (1995). Protein Kinase C isoform expression and ATP response change with smooth muscle cell differentiation. Biochemical Society Transactions. 23(3). 453S–453S. 1 indexed citations
8.
Assender, Jean W., Ewa Kontny, & Bertil B. Fredholm. (1994). Expression of protein kinase C isoforms in smooth muscle cells in various states of differentiation. FEBS Letters. 342(1). 76–80. 55 indexed citations
9.
Assender, Jean W., et al.. (1994). Transduction pathways for growth stimulatory and inhibitory actions of vasoactive agents.. PubMed. 2(2). 94–100. 2 indexed citations
10.
Assender, Jean W., Kay M. Southgate, Maurice B. Hallett, & Andrew C. Newby. (1992). Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochemical Journal. 288(2). 527–532. 94 indexed citations
11.
Assender, Jean W., et al.. (1992). Inhibition of vascular smooth muscle cell proliferation by endothelium-dependent vasodilators.. PubMed. 17(5). 291–9. 43 indexed citations
12.
Assender, Jean W., Kay M. Southgate, & Andrew C. Newby. (1991). Does Nitric Oxide Inhibit Smooth Muscle Proliferation?. Journal of Cardiovascular Pharmacology. 17(Supplement). 104???107–104???107. 14 indexed citations
13.
Assender, Jean W., Kay M. Southgate, & Andrew C. Newby. (1991). Does Nitric Oxide Inhibit Smooth Muscle Proliferation?. Journal of Cardiovascular Pharmacology. 17(Supplement 3). S104–S107. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Talat Afroze Breakdown of academic impact, for papers by Ursula Baur Breakdown of academic impact, for papers by Jérôme Terrand Breakdown of academic impact, for papers by R. Kast Breakdown of academic impact, for papers by Edith Giasson Breakdown of academic impact, for papers by Josef Pfeilschifter Breakdown of academic impact, for papers by A. Sandra Breakdown of academic impact, for papers by Ruqin Kou Breakdown of academic impact, for papers by P.G. Suh Breakdown of academic impact, for papers by Tasuku Yokota
Rankless by CCL
2026